No products in the cart.
Roll over image to zoom in
TEMMUNE MMF 500MG TABLET
₹450.00₹500.00 (-10%)
Temmune MMF 500mg Tablet is an anti-inflammatory with an active ingredient known as Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid rejection of organs in patients who have had one of their organs (such as heart, kidney, and liver transplantation). It is defined as a part of a treatment combination that includes other immunosuppressive medicines.
This medication is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. It should not be used for pregnant women unless there are no other alternatives and the advantages outweigh the risks. Women who are pregnant are advised to utilize the most effective contraception available when using this tablet to prevent pregnancies. Live vaccines shouldn’t be administered if a patient takes Temmune MMF500mg Tablet because of the decreased vaccine effectiveness and risk of contracting infection. Patients taking this medication must not give blood during treatment and at least six weeks after stopping treatment. It is a way to ensure that the drug is eliminated from the body before donating blood.
It is usually advised not to take this drug in case you have an allergy to the drug or other ingredients. Inform your doctor about heart or liver problems before starting the treatment because this medication reduces the body’s immune system and can increase the likelihood of developing skin cancer. People should reduce their exposure to UV (UV) radiation. Contact your doctor immediately in case of bruising on your skin or fever. Unprovoked fatigue, dizziness, or yellowing of the eyes or skin vision impairment, decreased urinary output, or seizures following this medication. Temmune MMF 500 mg Tablet is an immunosuppressive medication. It could affect a baby’s developing immune system and should not be used while breastfeeding. In certain instances, alternative medicines with an enhanced safety profile for breastfeeding can be thought of as.